The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib) [4]

Nikolas Von Bubnoff; Sivahari Prasad Gorantla; Silvia Thöne; Christian Peschel; Justus Duyster

doi:10.1182/blood-2006-01-0285

The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib) [4]

Nikolas Von Bubnoff^*, Sivahari Prasad Gorantla, Silvia Thöne, Christian Peschel, Justus Duyster

^*Corresponding author for this work

Clinic of Hematology and Oncology

Technical University of Munich

63 Citations (Scopus)

Original language	English
Journal	Blood
Volume	107
Issue number	12
Pages (from-to)	4970-4971
Number of pages	2
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2006-01-0285
Publication status	Published - 15.06.2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1182/blood-2006-01-0285

Cite this

@article{6d65533e6bb646769c75011b306aa878,

title = "The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib) [4]",

author = "\{Von Bubnoff\}, Nikolas and Gorantla, \{Sivahari Prasad\} and Silvia Th{\"o}ne and Christian Peschel and Justus Duyster",

year = "2006",

month = jun,

day = "15",

doi = "10.1182/blood-2006-01-0285",

language = "English",

volume = "107",

pages = "4970--4971",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "12",

}

TY - JOUR

T1 - The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib) [4]

AU - Von Bubnoff, Nikolas

AU - Gorantla, Sivahari Prasad

AU - Thöne, Silvia

AU - Peschel, Christian

AU - Duyster, Justus

PY - 2006/6/15

Y1 - 2006/6/15

UR - https://www.scopus.com/pages/publications/33745059630

U2 - 10.1182/blood-2006-01-0285

DO - 10.1182/blood-2006-01-0285

M3 - Letters

C2 - 16754777

AN - SCOPUS:33745059630

SN - 0006-4971

VL - 107

SP - 4970

EP - 4971

JO - Blood

JF - Blood

IS - 12

ER -

The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib) [4]

UN SDGs

Access to Document

Other files and links

Cite this